November 04, 2025

The Analytical Scientist Innovation Awards 2025: #9

Meet the team behind Bio-Rad’s Nuvia wPrime 2A Media: tunable mixed-mode chromatography for biomolecule purification

The Analytical Scientist

October 30, 2025

Overall Survival After Hormonal Therapy vs Hysterectomy in Early Endometrial Cancer

In a U.S. cohort study reported in JAMA Oncology, Suzuki et al assessed long-term survival among premenopausal women with clinical stage I endometrioid endometrial cancer treated with fertility-preser...

The ASCO Post

October 29, 2025

Online AI Tool Offers Rapid, Accurate Diagnosis for Endocrine Cancers

Researchers have developed a novel AI-powered online platform for diagnosing endocrine cancers with speed and accuracy. The AI models achieved diagnostic accuracy of 99% or more in recognizing multipl...

The ASCO Post

October 29, 2025

How the AI-Powered ASCO® Guidelines Assistant Is Improving Clinical Decision-Making

This past May, ASCO announced its collaboration with Google Cloud to launch the ASCO® Guidelines Assistant, a new interactive tool that allows clinicians to quickly access ASCO’s evidence-based clinic...

The ASCO Post

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 27, 2025

Reimagining Antibody Drug Discovery with AI

By focusing on functional activity, Abalone Bio is advancing CB2-targeting antibodies with the potential to transform treatment for fibrosis, neuropathy, and beyond.

The Medicine Maker

October 23, 2025

Roving Reporter Asks: What Are the Biggest Hurdles in Cell and Gene Therapy Development?

IBTV interviews show that funding and investment panic are dominating industry concerns.

The Medicine Maker

October 22, 2025

Tariffs, Talent, and Technology: Inside Pharma’s Executive Recruitment Landscape

As tariffs and geopolitical uncertainty continue to disrupt supply chains, a new kind of biotech and pharma executive is emerging.

The Medicine Maker

October 21, 2025

The Power List Personified: Getting to Know Fabian Gerlinghaus

Cellares CEO Fabian Gerlinghaus talks about automation, partnerships, and inspiration from Carl June.

The Medicine Maker